|
ISIN No
|
INE750C01026
|
BSE Code / NSE Code
|
524404 / MARKSANS
|
Book Value (Rs.)
|
70.23
|
Face Value
|
1.00
|
|
Bookclosure
|
20/08/2026
|
52Week High
|
351
|
EPS
|
9.22
|
P/E
|
35.31
|
|
Market Cap.
|
14755.01 Cr.
|
52Week Low
|
155
|
P/BV / Div Yield (%)
|
4.64 / 0.28
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view the investment break up of the company with details such as Security name, Security type, Company type, investmement cost etc.
| YearEnd | Security Name | Security Type | Company Type | Cost of Investments |
| 2603 |
Marksans Pharma Inc.
| Equity Share | Subsidiary | 168.19 |
| 2603 |
Marksans Pharma (UK) Ltd.
| Equity Share | Subsidiary | 67.76 |
| 2603 |
Access Healthcare for Medical Products LLC
| Equity Share | Subsidiary | 29.68 |
| 2603 |
Nova Pharmaceuticals Australasia Pty. Ltd.
| Equity Share | Subsidiary | 1.59 |